Status:
UNKNOWN
A Multicenter, Observational Clinical Study of Dydrogesterone
Lead Sponsor:
Guangdong Women and Children Hospital
Conditions:
Endometriosis
Endometriosis Ovary
Eligibility:
FEMALE
18-45 years
Brief Summary
The objective of this study was to investigate the efficacy and safety of dydrogesterone in the long-term management of ovarian endometriosis cyst after surgery.
Detailed Description
Endometriosis refers to the appearance, growth and infiltration of endometrial tissue (glands and stroma) in the lining of the uterine cavity and other parts of the uterus, and repeated bleeding, whic...
Eligibility Criteria
Inclusion
- Patients who had undergone laparoscopic ovarian cyst excision and were confirmed by pathological diagnosis as ovarian endometriosis cyst (pathology was completed in each central hospital).
- Ovarian cyst \>4cm.
- Concomitant infertility.
- Patients who fail to respond to medication.
- American Society of Reproductive Medicine(ASRM) stages were II-IV.
- No relevant therapeutic drugs, such as dydrogesterone, dienogest, GnRHa, etc., were used 3 months before treatment.
- No combined endocrine diseases.
Exclusion
- Ovulation disorders, immune defects and genital development abnormalities caused by infertility.
- Patients who are allergic to the drugs used in this study.
- Patients with severe hepatorenal insufficiency or malignant tumor.
- Those who took hormone medication within 3 months before the study date.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05976529
Start Date
January 1 2023
End Date
December 31 2025
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Women and Children Hospital
Guanzhou, Guangdong, China, 511400